Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial

多酚类酚 硬化疗法 医学 外科 随机对照试验 静脉曲张
作者
Karl-Heinz Moser,Christoph Mösch,Maren Walgenbach,Dieter Bussen,Jan Kirsch,A. Joós,Petra Gliem,Stefan Sauerland
出处
期刊:International Journal of Colorectal Disease [Springer Nature]
卷期号:28 (10): 1439-1447 被引量:55
标识
DOI:10.1007/s00384-013-1729-2
摘要

Sclerotherapy is the treatment of choice for first-grade haemorrhoidal disease. Numerous studies have shown that sclerotherapy with foamed sclerosants is more efficacious than liquid in the treatment of varicose veins. The aim of this study was to assess the efficacy and safety of polidocanol foam in comparison with liquid for haemorrhoidal disease. A total of 130 patients were randomised to foam or liquid sclerotherapy (polidocanol 3 %). Patients with first-grade haemorrhoidal disease were included and blinded to treatment assignment. The primary endpoint was the stopping of perianal bleeding after one sclerotherapy session. Sclerotherapy was repeated until patients were free of bleeding (2-week intervals). The final follow-up was 12 weeks after the last sclerotherapy session. In the foam group, significantly more patients (88 %) were treated successfully after one sclerotherapy session compared to the liquid group (69 %; p = 0.01). There was high patient satisfaction in both groups, but significantly more patients were satisfied with their treatment in the foam group than in the liquid group (99 vs. 84 %; p = 0.009). Additionally, in the foam group, significantly less treatment sessions were required (p < 0.001), and the total amount of injected polidocanol was reduced (p < 0.001). In the therapy of first-grade haemorrhoidal disease, polidocanol 3 % foam is more effective and equally safe compared to liquid polidocanol. The results of this trial show that foam sclerotherapy is a new, innovative, effective and safe non-surgical treatment option for haemorrhoidal disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可爱的函函应助薄荷采纳,获得10
刚刚
1秒前
xiao应助科研通管家采纳,获得20
1秒前
李健应助科研通管家采纳,获得10
1秒前
所所应助科研通管家采纳,获得10
1秒前
科目三应助科研通管家采纳,获得10
1秒前
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
涣醒完成签到,获得积分10
1秒前
科研通AI2S应助十泱采纳,获得10
2秒前
进退须臾发布了新的文献求助10
3秒前
3秒前
星辰大海应助wyw123采纳,获得10
6秒前
6秒前
7秒前
温婉的乞完成签到 ,获得积分10
8秒前
泪雨煊发布了新的文献求助10
10秒前
研友_VZG7GZ应助黄沙采纳,获得10
11秒前
杨金城发布了新的文献求助10
12秒前
包容的世倌关注了科研通微信公众号
13秒前
上进生发布了新的文献求助10
13秒前
lzm10010完成签到,获得积分10
14秒前
悦耳小馒头给悦耳小馒头的求助进行了留言
14秒前
14秒前
Leoniko完成签到,获得积分10
15秒前
16秒前
17秒前
123完成签到,获得积分10
18秒前
Wayne发布了新的文献求助10
18秒前
19秒前
想毕业的小橙子完成签到,获得积分10
20秒前
明白发布了新的文献求助10
20秒前
vic发布了新的文献求助10
22秒前
ding应助Leoniko采纳,获得10
23秒前
24秒前
哈哈哈哈嘻嘻嘻完成签到 ,获得积分10
24秒前
嘻嘻哈哈完成签到 ,获得积分10
25秒前
Akim应助杨金城采纳,获得30
25秒前
11111111完成签到,获得积分10
26秒前
星辰完成签到,获得积分10
26秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
A Dissection Guide & Atlas to the Rabbit 600
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 500
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufe 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3105137
求助须知:如何正确求助?哪些是违规求助? 2756288
关于积分的说明 7638684
捐赠科研通 2410249
什么是DOI,文献DOI怎么找? 1278761
科研通“疑难数据库(出版商)”最低求助积分说明 617495
版权声明 599262